09:56 AM EDT, 04/01/2024 (MT Newswires) -- NewAmsterdam Pharma ( NAMS ) said Monday that Juliette Audet has been named chief business officer and has resigned from the company's board, effective immediately.

Audet most recently served as a partner at Forbion, contributing to the team that established NewAmsterdam Pharma ( NAMS ), the company said.

Price: 22.78, Change: -0.87, Percent Change: -3.71